Karyopharm Therapeutics, Inc. (KPTI)
8.77
-0.05
(-0.57%)
USD |
NASDAQ |
Mar 06, 16:00
8.77
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics SG&A Expense (TTM) : 105.21M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Baxter International, Inc. | 2.89B |
| Bruker Corp. | 946.50M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Agios Pharmaceuticals, Inc. | 180.28M |